Home / RCBTB2 Knockout Cell Lines

RCBTB2 Knockout Cell Lines

Gene: RCBTB2

Official Full Name: RCC1 and BTB domain containing protein 2provided by HGNC

Gene Summary: This gene encodes a protein containing two C-terminal BTB/POZ domains that is related to regulator of chromosome condensation (RCC). The encoded protein may act as a guanine nucleotide exchange factor. This gene is observed to be lost or underexpressed in prostate cancers. There is a pseudogene of this gene on chromosome 10. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2013]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO38567 RCBTB2 Knockout cell line (HeLa) Human RCBTB2 1:3~1:6 Negative Online Inquiry
KO38568 RCBTB2 Knockout cell line (HCT 116) Human RCBTB2 1:2~1:4 Negative Online Inquiry
KO38569 RCBTB2 Knockout cell line (HEK293) Human RCBTB2 1:3~1:6 Negative Online Inquiry
KO38570 RCBTB2 Knockout cell line (A549) Human RCBTB2 1:3~1:4 Negative Online Inquiry

Background

RCBTB2 Gene Knockout Cell Lines are genetically engineered cellular models that facilitate the study of the RCBTB2 gene and its biological implications. By employing cutting-edge CRISPR-Cas9 technology, these cell lines have been specifically designed to exhibit a complete knockout of the RCBTB2 gene, allowing for the investigation of gene function and the molecular pathways in which it is involved. The knockout mechanism not only enables researchers to observe phenotypic changes resulting from the absence of RCBTB2 but also assists in understanding its role in cellular processes such as proliferation, differentiation, and stress responses.

The scientific importance of RCBTB2 Gene Knockout Cell Lines lies in their potential for advancing fundamental research and therapeutic development. Given the growing body of evidence linking the RCBTB2 gene to various diseases, including certain cancers and neurological disorders, these cell lines serve as valuable tools for elucidating the gene's contribution to pathophysiology. In clinical research settings, they can be leveraged for screening potential therapeutic compounds, assessing drug efficacy, and understanding resistance mechanisms.

One of the standout advantages of using RCBTB2 Gene Knockout Cell Lines over conventional models is their specificity and reliability. Unlike less targeted approaches, these cell lines provide a precise deletion of the gene of interest, thereby reducing experimental variability and enhancing reproducibility. Moreover, the ability to customize these cell lines to study additional genetic markers or co-expressions offers a unique flexibility that traditional cell lines do not provide.

For researchers and clinicians alike, the RCBTB2 Gene Knockout Cell Lines represent an invaluable resource that accelerates discovery and innovation in gene-function studies and drug development. Our commitment to quality and scientific rigor ensures that these cell lines are thoroughly validated and characterized, making them a dependable choice for any laboratory looking to push the boundaries of biological research. Through our expertise in genetic engineering and cell line production, we empower the scientific community with tools that lead to impactful discoveries.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.